glp 1 agonist route of administration Frontiers The New Weight Management Meds

DETERMINING THE CONNECTION The results of these clinical trials prompted an important research question: Do GLP-1 RAs cause or worsen DR

Rather than viewing glucagon as a metabolic enemy, researchers now recognize that balancing its effects alongside GLP-1 and GIP may unlock a new generation of diabetes and obesity treatments

10.1186/s12916-023-02753-6 76 ZhouH.-R.MaX.-F.LinW.-J.HaoM.YuX.-Y.LiH.-X.et al (2021)

But these are much less convenient than the self-injector pens I am accustomed to

Signaling in VSMC The abnormal proliferation and migration of VSMCs are key events in plaque growth and instability

doi: 10.2337/dbi21-0004 64 FriasJPDaviesMJRosenstockJPerez ManghiFCFernandez LandoLBergmanBKet al